“Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S3. doi:10.25251/skin.2.supp.3.